Antibodies to early Epstein-Barr virus-induced antigens in Burkitt's lymphoma.
D000328:Adult; D000906:Antibodies; D000918:Antibody Specificity; D000937:Antigen-Antibody Reactions; D000941:Antigens / Q000032:analysis; D002051:Burkitt Lymphoma / Q000453:epidemiology / Q000276:immunology* / Q000382:microbiology / Q000401:mortality; D002648:Child; D002675:Child, Preschool; D005260:Female; D006564:Herpesviridae / Q000276:immunology*; D006566:Herpesviridae Infections / Q000276:immunology; D006801:Humans; D007106:Immune Sera / Q000032:analysis; D007630:Kenya; D008297:Male; D009364:Neoplasm Recurrence, Local; D009365:Neoplasm Regression, Spontaneous; D011233:Precipitin Tests; D011379:Prognosis; D013997:Time Factors; D014454:Uganda; D014777:Virus Diseases / Q000453:epidemiology
D000906:Antibodies; D000941:Antigens; D007106:Immune Sera